Santhera Pharmaceuticals Holding financials at a glance

+ Portfolio

The revenue of Santhera Pharmaceuticals Holding is reported as 0.00747 billion Switzerland Francs in the fiscal year 2023. The earnings were -11.7 Switzerland Francs per share in 2023, which was 27.78 higher than 2021. And about -0.03086 billion Switzerland Francs are reported as free cash flow in the financials of Santhera Pharmaceuticals Holding 2023. No dividends were paid to the shareholders of the Santhera Pharmaceuticals Holding stock SWX:SANN in the financial year 2023.

CHF7.47M

Revenue

CHF-11.70

Earnings Per Share

51.93%

Gross Margin %

CHF-29.80M

Free Cash Flow

Revenue

7.47

Earnings Per Share

-11.70

Gross Margin %

51.93

Free Cash Flow

-29.80

Financials

Year	Year	TTM	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2011	2010	2009	2008	2007	2006
Rev.	Revenue	N/A	CHF7.47M	CHF-1.60M	CHF15.01M	CHF75.38M	CHF31.66M	CHF22.94M	CHF19.03M	CHF4.30M	CHF2.59M	CHF0.00M	CHF3.27M	CHF20.61M	CHF22.10M	CHF0.05M	CHF9.23M	CHF0.78M
GM %	Gross Margin %	29.39%	51.93%	0.00%	70.49%	92.77%	85.15%	82.11%	79.60%	68.27%	92.32%	89.39%	89.65%	98.17%	98.91%	52.08%	100.00%	100.00%
OM	Operating Margin	0.00%	0.00%	0.00%	-,257.30%	-13.85%	-,162.43%	-,219.91%	-,174.05%	0.00%	0.00%	0.00%	0.00%	-42.27%	-,115.92%	0.00%	0.00%	0.00%
EPS	Earnings Per Share	CHF-7.32	CHF-11.70	CHF-16.20	CHF-50.80	CHF-17.30	CHF-78.60	CHF-82.20	CHF-56.50	CHF-38.40	CHF-16.00	CHF-15.50	CHF-76.00	CHF-30.80	CHF-73.10	CHF-,135.80	CHF-57.10	CHF-,144.40
Div.	Dividends	N/A	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00
PR %	Payout Ratio %	0	0	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	6.59M	4.96M	1.81M	1.11M	1.06M	0.63M	0.63M	0.63M	0.5M	0.39M	0.37M	0.37M	0.37M	0.35M	0.31M	0.31M
OCF	Operating Cash Flow	N/A	CHF-29.74M	CHF-37.36M	CHF-43.15M	CHF2.60M	CHF-37.87M	CHF-39.63M	CHF-27.14M	CHF-22.39M	CHF0.00M	CHF0.00M	CHF0.00M	CHF-6.64M	CHF-20.75M	CHF-45.69M	CHF-19.95M	CHF-23.90M
FCF	Free Cash Flow	N/A	CHF-29.80M	CHF-37.36M	CHF-43.54M	CHF2.50M	CHF-43.77M	CHF-61.87M	CHF-27.60M	CHF-22.74M	CHF0.00M	CHF0.00M	CHF0.00M	CHF-6.73M	CHF-20.97M	CHF-46.44M	CHF-20.41M	CHF-24.80M
FCFS	Free Cash Flow Per Share	CHF-4.21	CHF-5.55	CHF-1.09	CHF-3.27	CHF0.22	CHF-8.63	CHF-6.54	CHF-4.39	CHF-4.29	CHF-1.33	CHF-1.88	CHF-5.45	CHF-1.84	CHF-5.92	CHF-14.72	CHF-5.86	CHF-12.82

Santhera Pharmaceuticals Holding financials at a glance

Financials

Discover